Sponsorship declaration
This event was developed by Zurich/London Heart House. AstraZeneca, Novo Nordisk, Novartis, Menarini, Amgen, Boehringer Ingelheim and Lifeyear have provided sponsorships in the form of financial support towards this event. The sponsoring companies have had no influence over the agenda, content development or choice of speakers, except for the sponsored symposia presentations, which are organised by the respective named sponsor per session. The sponsoring companies have been granted exhibition space at this conference.
Postgraduate Course in Cardiometabolic Medicine 2026
This course contains presentations on subjects such as:
-
Obesity, Comorbidities and their management
-
Lifestyle and cardiovascular prevention
-
ASCVD Assessment & Management
-
Diabetes mellitus (DM)
-
Metabolic dysfunction-associated steatotic liver disease (MASLD)
-
Endocrinology and Cardiovascular disease
-
Nephrology - Chronic kidney disease (CKD) – Causes & Mechanisms
-
Cardiovascular risk in myocardial disease
-
Heart failure